Works matching IS 13524585 AND DT 2017 AND VI 23 AND IP 10


Results: 19
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

    Published in:
    Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1346, doi. 10.1177/1352458516679893
    By:
    • Spelman, Tim;
    • Meyniel, Claire;
    • Rojas, Juan Ignacio;
    • Lugaresi, Alessandra;
    • Izquierdo, Guillermo;
    • Grand’Maison, Francois;
    • Boz, Cavit;
    • Alroughani, Raed;
    • Havrdova, Eva;
    • Horakova, Dana;
    • Iuliano, Gerardo;
    • Duquette, Pierre;
    • Terzi, Murat;
    • Grammond, Pierre;
    • Hupperts, Raymond;
    • Lechner-Scott, Jeannette;
    • Oreja-Guevara, Celia;
    • Pucci, Eugenio;
    • Verheul, Freek;
    • Fiol, Marcela
    Publication type:
    Article
    13
    14
    15

    Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.

    Published in:
    Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1377, doi. 10.1177/1352458516678474
    By:
    • Montcuquet, Alexis;
    • Collongues, Nicolas;
    • Papeix, Caroline;
    • Zephir, Helene;
    • Audoin, Bertrand;
    • Laplaud, David;
    • Bourre, Bertrand;
    • Brochet, Bruno;
    • Camdessanche, Jean-Philippe;
    • Labauge, Pierre;
    • Moreau, Thibault;
    • Brassat, David;
    • Stankoff, Bruno;
    • de Seze, Jerome;
    • Vukusic, Sandra;
    • Marignier, Romain
    Publication type:
    Article
    16
    17
    18
    19